O

Organovo Holdings
D

ONVO

0.39000
USD
0.02
(5.41%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
5,992,672
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    C
    CRSP
    -2.620
    (-5.19%)
    47.840 USD
    E
    EDIT
    -0.14000
    (-6.80%)
    1.92000 USD
    E
    EXAS
    -0.270
    (-0.55%)
    49.250 USD
    N
    NTLA
    -0.075
    (-0.61%)
    12.180 USD
    P
    PACB
    -0.11000
    (-6.71%)
    1.53000 USD
    S
    STEM
    -0.09950
    (-14.99%)
    0.56440 USD
    T
    TDOC
    -1.190
    (-9.38%)
    11.490 USD
    V
    VCEL
    -2.230
    (-4.11%)
    52.060 USD
    المزيد
الأخبار
المقالات

العنوان: Organovo Holdings

القطاع: Healthcare
الصناعة: Biotechnology
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.